Increased variability in BRCA1-associated breast tumours was also observed in linear models of gene-specific CVs (25.0%, 95% CI 24.5–25.6) and MADs (32.4%, 95% CI 31.9–33.0). Here, BRCA1 is linked to breast neoplasm.